Aarey Drugs & Pharmaceuticals Limited Asset Resilience Ratio

Latest as of September 2025: 0.34%

Aarey Drugs & Pharmaceuticals Limited asset resilience ratio. Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has an Asset Resilience Ratio of 0.34% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See AAREYDRUGS defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs9.99 Million

≈ $108.02K USD Cash + Short-term Investments

Total Assets

Rs2.94 Billion

≈ $31.79 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Aarey Drugs & Pharmaceuticals Limited (2013–2025)

Asset resilience ratio of Aarey Drugs & Pharmaceuticals Limited from 2013 to 2025. This chart shows how Aarey Drugs & Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Read Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Aarey Drugs & Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Aarey Drugs & Pharmaceuticals Limited total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs9.99 Million	0.34%
Total Liquid Assets	Rs9.99 Million	0.34%

Asset Resilience Insights

Limited Liquidity: Aarey Drugs & Pharmaceuticals Limited maintains only 0.34% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Aarey Drugs & Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Aarey Drugs & Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Aarey Drugs & Pharmaceuticals Limited Asset Resilience Ratio by Year (2013–2025)

Aarey Drugs & Pharmaceuticals Limited asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Aarey Drugs & Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.74%	Rs17.56 Million ≈ $189.92K	Rs2.38 Billion ≈ $25.77 Million	+0.31pp
2024-03-31	0.43%	Rs12.95 Million ≈ $140.09K	Rs3.03 Billion ≈ $32.80 Million	+0.28pp
2023-03-31	0.14%	Rs4.18 Million ≈ $45.21K	Rs2.91 Billion ≈ $31.51 Million	-2.92pp
2022-03-31	3.06%	Rs75.07 Million ≈ $811.83K	Rs2.45 Billion ≈ $26.51 Million	+3.06pp
2021-03-31	0.01%	Rs129.95K ≈ $1.41K	Rs2.33 Billion ≈ $25.20 Million	0.00pp
2020-03-31	0.01%	Rs154.05K ≈ $1.67K	Rs1.94 Billion ≈ $20.99 Million	-0.01pp
2019-03-31	0.02%	Rs232.72K ≈ $2.52K	Rs1.46 Billion ≈ $15.76 Million	-1.67pp
2018-03-31	1.69%	Rs28.66 Million ≈ $309.95K	Rs1.70 Billion ≈ $18.36 Million	+1.39pp
2017-03-31	0.30%	Rs4.34 Million ≈ $46.91K	Rs1.43 Billion ≈ $15.49 Million	+0.27pp
2015-03-31	0.03%	Rs400.00K ≈ $4.33K	Rs1.15 Billion ≈ $12.43 Million	0.00pp
2014-03-31	0.04%	Rs400.00K ≈ $4.33K	Rs1.07 Billion ≈ $11.56 Million	+0.00pp
2013-03-31	0.04%	Rs400.00K ≈ $4.33K	Rs1.07 Billion ≈ $11.58 Million	--

pp = percentage points

About Aarey Drugs & Pharmaceuticals Limited

NSE:AAREYDRUGS India Drug Manufacturers - Specialty & Generic

Market Cap

$33.51 Million

Rs3.10 Billion INR

Market Cap Rank

#23185 Global

#1281 in India

Share Price

Rs109.29

Change (1 day)

+3.34%

52-Week Range

Rs50.75 - Rs113.87

All Time High

Rs113.87